BOSTON, Oct 14 (Reuters) - Genzyme Corp said on Sunday that three-year data from a mid-stage trial of its experimental multiple sclerosis drug showed it to be very effective, but patients must be ...
FRANKFURT, Aug 30 (Reuters) - German drug maker Merck KGaA's Merck Serono unit won European Commission approval to market a new formulation of its Rebif drug to treat relapsing multiple sclerosis, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results